Chin Richard
Chief Executive Officer at Kindred Biosciences, Inc.; Director at SLS
- Sold, on record
- $7.1M
- Dollars the filings state
- Form 4 sales
- 20
- Latest Aug 2, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Kindred Biosciences, Inc.Chief Executive Officer
- SLSSELLAS Life Sciences Group, Inc.Director
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Kindred Biosciences, Inc.526,000 shares
- SLS262,500 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Kindred Biosciences, Inc.Plan not statedSep 5 2018
Sold 40,000 shares at $14.79 ($591k)
Chin Richard, PRESIDENT AND CEO
Sold 1.9% of holdings ($31.1M position)2.1M shares left2.4x usual sizeFiling
- 2 Form 4 sale Kindred Biosciences, Inc.Plan not statedOct 1 +26 days
Sold 40,000 shares at $13.28 ($531k)
Chin Richard, President and CEO
Sold 1.9% of holdings ($27.4M position)2M shares left2x usual sizeFiling
- 3 Form 4 sale Kindred Biosciences, Inc.Plan not statedNov 1 +31 days
Sold 40,000 shares at $14.68 ($587k)
Chin Richard, CEO
Sold 2% of holdings ($29.7M position)2M shares left2x usual sizeFiling
- 4 Form 4 sale Kindred Biosciences, Inc.Plan not statedDec 3 +32 days
Sold 40,000 shares at $13.28 ($531k)
Chin Richard, Chief Executive Officer
Sold 2% of holdings ($26.4M position)1.9M shares left2x usual sizeFiling
- 5 Form 4 sale Kindred Biosciences, Inc.Plan not statedJan 2 +30 days
Sold 40,000 shares at $10.57 ($423k)
Chin Richard, Chief Executive Officer
Sold 2.1% of holdings ($20.6M position)1.9M shares left1.3x usual sizeFiling
- 6 Form 4 sale Kindred Biosciences, Inc.Plan not statedJun 16 +896 days
Sold 40,000 shares at $9.18 ($367k)
Chin Richard, Chief Executive Officer
Sold 2% of holdings ($18.1M position)1.9M shares leftFirst sale on recordFiling
- 7 Form 4 sale Kindred Biosciences, Inc.Plan not statedJul 2 +16 days
Sold 40,000 shares at $9.18 ($367k)
Chin Richard, Chief Executive Officer
Sold 2.1% of holdings ($17.8M position)1.9M shares leftFiling
- 8 Form 4 sale Kindred Biosciences, Inc.Plan not statedAug 2 +31 days
Sold 40,000 shares at $9.21 ($368k)
Chin Richard, Chief Executive Officer
Sold 2.5% of holdings ($14.5M position)1.5M shares leftFiling
Every transaction
Loading transactions…
Sales and notices (20)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Aug 2, 2021 | Kindred Biosciences, Inc. | Chief Executive Officer | Form 4 sale | 40,000 | $368k | 2.5% | Plan not stated | SEC |
| Jul 2, 2021 | Kindred Biosciences, Inc. | Chief Executive Officer | Form 4 sale | 40,000 | $367k | 2.1% | Plan not stated | SEC |
| Jun 16, 2021 | Kindred Biosciences, Inc. | Chief Executive Officer | Form 4 sale | 40,000 | $367k | 2.0% | Plan not stated | SEC |
| Jan 2, 2019 | Kindred Biosciences, Inc. | Chief Executive Officer | Form 4 sale | 40,000 | $423k | 2.1% | Plan not stated | SEC |
| Dec 3, 2018 | Kindred Biosciences, Inc. | Chief Executive Officer | Form 4 sale | 40,000 | $531k | 2.0% | Plan not stated | SEC |
| Nov 1, 2018 | Kindred Biosciences, Inc. | CEO | Form 4 sale | 40,000 | $587k | 2.0% | Plan not stated | SEC |
| Oct 1, 2018 | Kindred Biosciences, Inc. | President and CEO | Form 4 sale | 40,000 | $531k | 1.9% | Plan not stated | SEC |
| Sep 5, 2018 | Kindred Biosciences, Inc. | PRESIDENT AND CEO | Form 4 sale | 40,000 | $591k | 1.9% | Plan not stated | SEC |
| Aug 1, 2018 | Kindred Biosciences, Inc. | President and CEO | Form 4 sale | 40,000 | $540k | 1.9% | Unusual | SEC |
| Jul 2, 2018 | Kindred Biosciences, Inc. | President and CEO | Form 4 sale | 40,000 | $411k | 1.8% | Unusual | SEC |
| Jun 1, 2018 | Kindred Biosciences, Inc. | President and CEO | Form 4 sale | 52,610 | $531k | 2.4% | Unusual | SEC |
| May 25, 2018 | Kindred Biosciences, Inc. | President and CEO | Form 4 sale | 3,060 | $31k | 0.1% | Plan not stated | SEC |
| May 18, 2018 | Kindred Biosciences, Inc. | President and CEO | Form 4 sale | 2,400 | $24k | 0.1% | Plan not stated | SEC |
| May 9, 2018 | Kindred Biosciences, Inc. | President and CEO | Form 4 sale | 1,930 | $19k | 0.1% | Plan not stated | SEC |
| May 1, 2018 | Kindred Biosciences, Inc. | President and CEO | Form 4 sale | 20,000 | $181k | 0.9% | Plan not stated | SEC |
| Apr 2, 2018 | Kindred Biosciences, Inc. | President and CEO | Form 4 sale | 20,000 | $168k | 0.9% | Plan not stated | SEC |
| Jul 3, 2017 | Kindred Biosciences, Inc. | President and CEO | Form 4 sale | 13,000 | $107k | 0.6% | Plan not stated | SEC |
| Jun 22, 2017 | Kindred Biosciences, Inc. | President and CEO | Form 4 sale | 13,000 | $101k | 0.6% | Plan not stated | SEC |
| Feb 12, 2014 | SLS | Director | Form 4 sale | 187,500 | $812k | 100.0% | Unusual | SEC |
| Jan 30, 2014 | SLS | Director | Form 4 sale | 75,000 | $419k | 100.0% | Unusual | SEC |